Search

Your search keyword '"Annemieke J.M. Rozemuller"' showing total 37 results
Start Over Author "Annemieke J.M. Rozemuller" Journal alzheimer's & dementia
37 results on '"Annemieke J.M. Rozemuller"'

1. Neuroinflammation connecting amyloid‐beta and p‐tau pathology, may explain clinical heterogeneity in Alzheimer’s disease

Author

Baayla D.C. Boon, Jeroen J.M. Hoozemans, Annemieke J.M. Rozemuller, Femke H. Bouwman, Irene Frigerio, Laura E. Jonkman, Naomi Kouri, Dennis W. Dickson, and Melissa E. Murray

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Neurology (clinical), Geriatrics and Gerontology
Published
2022
Full Text
View/download PDF

2. A novel type of amyloid‐beta plaques identified in early‐onset AD

Author

Remco Natté, Wilma D.J. van de Berg, Marko Popovic, Allert J. Jonker, Jochen Walter, Jeroen J.M. Hoozemans, Annemieke J.M. Rozemuller, Femke H. Bouwman, Louise van der Weerd, Sathish Kumar, Baayla D.C. Boon, and Marjolein Bulk

Subjects
Pathology, medicine.medical_specialty, biology, Epidemiology, business.industry, Amyloid beta, Health Policy, Disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, medicine, biology.protein, Neurology (clinical), Geriatrics and Gerontology, business, Pathological, Early onset
Published
2020
Full Text
View/download PDF

3. Investigating Aβ plaque development using FTIR micro‐spectroscopy on native postmortem human brain tissue

Author

Femke H. Bouwman, Annemieke J.M. Rozemuller, Baayla D.C. Boon, Jeroen J.M. Hoozemans, Frederik Großerüschkamp, Klaus Gerwert, and Dominik Röhr

Subjects
Pathology, medicine.medical_specialty, Epidemiology, Chemistry, Health Policy, Neuropathology, Human brain, Psychiatry and Mental health, Cellular and Molecular Neuroscience, medicine.anatomical_structure, Developmental Neuroscience, medicine, Micro spectroscopy, Neurology (clinical), Geriatrics and Gerontology
Published
2020
Full Text
View/download PDF

4. Neuropathology of FMR1‐premutation carriers presenting with dementia and neuropsychiatric symptoms

Author

Peter K. Todd, Wilfred F. A. den Dunnen, Jeroen J.M. Hoozemans, Nicolas Charlet-Berguerand, Anke A. Dijkstra, Annemieke J.M. Rozemuller, Saif N Haify, Rob Willemsen, Esmay C van der Toorn, Marianna Bugiani, Nicolaas A. Verwey, Renate K. Hukema, and Niels D. Prins

Subjects
0303 health sciences, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Neuropathology, medicine.disease, FMR1, 03 medical and health sciences, Psychiatry and Mental health, Cellular and Molecular Neuroscience, 0302 clinical medicine, Developmental Neuroscience, medicine, Dementia, Neurology (clinical), Geriatrics and Gerontology, Psychiatry, business, 030217 neurology & neurosurgery, 030304 developmental biology
Published
2020
Full Text
View/download PDF

5. Dissecting frontotemporal dementia: Correlations between neuropsychiatric symptoms and neuropathology

Author

Harro Seelaar, Anke A. Dijkstra, Annemieke J.M. Rozemuller, Daniela Galimberti, Yolande A.L. Pijnenburg, Priya Gami-Patel, Netherlands Brain Bank, John C. van Swieten, Annemiek Dols, Marta Scarioni, Elio Scarpini, Jeroen J.M. Hoozemans, and Yannick Timar

Subjects
Pathology, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Neuropathology, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Medicine, Neurology (clinical), Geriatrics and Gerontology, business, Frontotemporal dementia
Published
2020
Full Text
View/download PDF

6. The presence of Alzheimer’s disease pathology in dementia with Lewy bodies is related to increased neocortical α‐synuclein load and different α‐synuclein morphology

Author

Emma van den Berg, Netherlands Brain Bank, Afina W. Lemstra, Hanneke Geut, Annemieke J.M. Rozemuller, and Wilma D.J. van de Berg

Subjects
Alpha-synuclein, Pathology, medicine.medical_specialty, Epidemiology, Dementia with Lewy bodies, Health Policy, Neuropathology, Disease, Biology, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, chemistry.chemical_compound, Developmental Neuroscience, chemistry, medicine, α synuclein, Neurology (clinical), Geriatrics and Gerontology
Published
2020
Full Text
View/download PDF

7. Increased Aβ pathology associated with increasing fractional anisotropy in the nucleus basalis of Meynert: A postmortem MRI and histopathology study

Author

Annemieke J.M. Rozemuller, Irene Frigerio, Menno M. Schoonheim, Baayla D.C. Boon, Femke H. Bouwman, Chen-Pei Lin, L. E. Jonkman, Zihan Zhou, Martijn D. Steenwijk, and Wilma D.J. van de Berg

Subjects
Pathology, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Neuropathology, Nucleus basalis, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Fractional anisotropy, medicine, Histopathology, Neurology (clinical), Geriatrics and Gerontology, business
Published
2020
Full Text
View/download PDF

8. Distribution of pathological hallmarks and association with post‐mortem MRI cortical thickness in typical and atypical Alzheimer’s disease

Author

Martijn D. Steenwijk, Irene Frigerio, Wilma D.J. van de Berg, Femke H. Bouwman, Baayla D.C. Boon, Paolo Preziosa, Annemieke J.M. Rozemuller, Jeroen J.M. Hoozemans, and L. E. Jonkman

Subjects
Pathology, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Medicine, Distribution (pharmacology), Neurology (clinical), Geriatrics and Gerontology, business, Pathological
Published
2020
Full Text
View/download PDF

9. [P3–427]: NON‐AMNESTIC ALZHEIMER's DISEASE: A POSSIBLE ROLE FOR NEUROINFLAMMATION?

Author

Philip Scheltens, Femke H. Bouwman, Annemieke J.M. Rozemuller, B. D. C. Boon, and Jeroen J.M. Hoozemans

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, business.industry, Health Policy, Medicine, Neurology (clinical), Disease, Geriatrics and Gerontology, business, Neuroscience, Neuroinflammation
Published
2017
Full Text
View/download PDF

10. [O5–07–04]: COGNITIVE PERFORMANCE AND ALZHEIMER‐ASSOCIATED PATHOLOGY IN THE CONTEXT OF EXTREME AGING

Author

Nina Beker, Jeroen J.M. Hoozemans, Andrea B. Ganz, Philip Scheltens, Sietske A.M. Sikkes, Annemieke J.M. Rozemuller, and Henne Holstege

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Context (language use), Neurology (clinical), Effects of sleep deprivation on cognitive performance, Geriatrics and Gerontology, Psychology, Cognitive psychology, Developmental psychology
Published
2017
Full Text
View/download PDF

11. [O1–08–05]: MISMATCH BETWEEN CLINICAL AND NEUROPATHOLOGICAL DIAGNOSIS OF DEMENTIA: HOW CAN BIOMARKERS HELP?

Author

Annemieke J.M. Rozemuller, Philip Scheltens, Charlotte E. Teunissen, Baayla D.C. Boon, Wiesje M. van der Flier, and Femke H. Bouwman

Subjects
medicine.medical_specialty, Epidemiology, business.industry, Health Policy, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, medicine, Dementia, Neurology (clinical), Geriatrics and Gerontology, Intensive care medicine, business
Published
2017
Full Text
View/download PDF

12. [P3–422]: CLINICAL AND RADIOLOGICAL FINDINGS IN PATIENTS WITH PATHOLOGICALLY CONFIRMED CAA

Author

Wiesje M. van der Flier, Femke H. Bouwman, Frederik Barkhof, Annemieke J.M. Rozemuller, Philip Scheltens, Jolien F. Leijenaar, Wiesje Pelkmans, and Niels D. Prins

Subjects
medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Surgery, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Radiological weapon, Medicine, In patient, Neurology (clinical), Geriatrics and Gerontology, business
Published
2017
Full Text
View/download PDF

13. P1‐123: Differential Expression in Hippocampus of Alzheimer's Disease Patients

Author

Shami Melhem, Jeroen van Rooij, John C. van Swieten, Annemieke J.M. Rozemuller, Diana A. T. Nijholt, Joyce B. J. van Meurs, Lieke H.H. Meeter, and André G. Uitterlinden

Subjects
Epidemiology, business.industry, Health Policy, Hippocampus, Disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Medicine, Neurology (clinical), Geriatrics and Gerontology, Differential expression, business, Neuroscience
Published
2016
Full Text
View/download PDF

14. P1‐339: Different Pathological Distribution Pattern of Phosphorylated TAU and Microglia in Amnestic and Non‐Amnestic Alzheimer’s Disease

Author

Roel Klaver, Wouter Kamphorst, Annemieke J.M. Rozemuller, J. J. M. Hoozemans, Femke H. Bouwman, Wilma D.J. van de Berg, Philip Scheltens, Pieter Voorn, and Baayla D.C. Boon

Subjects
Pathology, medicine.medical_specialty, Microglia, Epidemiology, business.industry, Health Policy, Disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, medicine.anatomical_structure, Developmental Neuroscience, Distribution pattern, Tau phosphorylation, Medicine, Neurology (clinical), Geriatrics and Gerontology, business, Pathological
Published
2016
Full Text
View/download PDF

15. O4‐08‐04: Heterogeneous histopathology of caa‐related cortical microbleeds

Author

Annemieke J.M. Rozemuller, Susanne J. van Veluw, Geert Jan Biessels, and Catharina J.M. Klijn

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, medicine.medical_specialty, Pathology, Developmental Neuroscience, Epidemiology, business.industry, Health Policy, medicine, Histopathology, Neurology (clinical), Geriatrics and Gerontology, business
Published
2015
Full Text
View/download PDF

16. P1‐218: Cerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces

Author

Annemieke J.M. Rozemuller, Susanne J. van Veluw, Steven M. Greenberg, Peter R. Luijten, Willem H. Bouvy, Anand Viswanathan, Wim G. M. Spliet, M. Edip Gurol, Geert J. Biessels, Eric A. Macklin, Sergi Martinez-Ramirez, and Jaco J.M. Zwanenburg

Subjects
Pathology, medicine.medical_specialty, medicine.diagnostic_test, Epidemiology, business.industry, Health Policy, Magnetic resonance imaging, medicine.disease, Dilated perivascular spaces, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Tissue sections, medicine.anatomical_structure, Developmental Neuroscience, Neuroimaging, mental disorders, Centrum semiovale, Medicine, Neurology (clinical), Small vessel, Cerebral amyloid angiopathy, Geriatrics and Gerontology, Perivascular space, business
Abstract

Perivascular spaces are an emerging marker of small vessel disease. Perivascular spaces in the centrum semiovale have been associated with cerebral amyloid angiopathy. However, a direct topographical relationship between dilated perivascular spaces and cerebral amyloid angiopathy severity has not been established. We examined this association using post-mortem magnetic resonance imaging in five cases with evidence of cerebral amyloid angiopathy pathology. Juxtacortical perivascular spaces dilation was evaluated on T2 images and related to cerebral amyloid angiopathy severity in overlying cortical areas on 34 tissue sections stained for Amyloid β. Degree of perivascular spaces dilation was significantly associated with cerebral amyloid angiopathy severity (odds ratio = 3.3, 95% confidence interval 1.3-7.9, p = 0.011). Thus, dilated juxtacortical perivascular spaces are a promising neuroimaging marker of cerebral amyloid angiopathy severity.

Published
2015
Full Text
View/download PDF

17. F2‐03‐03: Characterization of the behavioral and dysexecutive variants of Alzheimer's disease

Author

Yolande A.L. Pijnenburg, Annemieke J.M. Rozemuller, Wiesje M. van der Flier, Philip Scheltens, Eric J. Huang, William J. Jagust, William W. Seeley, Bart N.M. van Berckel, Howard J. Rosen, Annelies E. van der Vlies, Nienke M.E. Scheltens, Lea T. Grinberg, Brendan I. Cohn-Sheehy, Frederik Barkhof, Renaud La Joie, Bruce L. Miller, Gil D. Rabinovici, Joel H. Kramer, Rik Ossenkoppele, Jacob W. Vogel, and David C. Perry

Subjects
Genetics, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, business.industry, Health Policy, Medicine, Neurology (clinical), Disease, Geriatrics and Gerontology, business
Published
2015
Full Text
View/download PDF

18. S4‐01‐01: Pathology of cognitively healthy centenarians

Author

Annemieke J.M. Rozemuller, Neline van Woerden, Jeroen M.M. Hoozemans, Karlijn Pieterse, Henne Holstege, Hanne Meijers-Heijboer, Kimja Schouten, Philip Scheltens, and Elizabeth Wemmenhove

Subjects
Gerontology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, business.industry, Health Policy, Medicine, Neurology (clinical), Geriatrics and Gerontology, business
Published
2015
Full Text
View/download PDF

19. P1‐096: IRAK‐4 KINASE INHIBITION REDUCES PRO‐INFLAMMATORY CYTOKINE SECRETION BUT HAS NO EFFECT ON THE UPTAKE OF AMYLOID BETA BY HUMAN GLIAL CELLS

Author

Sandra D. Mulder, Annemieke J.M. Rozemuller, Henrietta M. Nielsen, R. Veerhuis, Jeroen J.M. Hoozemans, Elise S. van Haastert, Saskia M. van der Vies, Riet Hilhorst, and Rob Ruijtenbeek

Subjects
Innate immune system, biology, Epidemiology, Amyloid beta, Health Policy, Inflammation, Proinflammatory cytokine, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Chemokine receptor, Immune system, Developmental Neuroscience, Biochemistry, Immunology, medicine, biology.protein, Cytokine secretion, Neurology (clinical), Geriatrics and Gerontology, medicine.symptom, Decoy receptors
Abstract

which function in innate immunity also suggests that innate immunity may have a significant role in AD. Given that gliosis occurs at least decades earlier than the first appearance of clinical symptoms in AD, it is conceivable that glial dysfunction and mis-activation of the innate immune system drives AD type neurodegeneration.However, very few studies have directly addressed how inflammation per se drives Ab or tau pathology.To characterize the role of innate immunefactors on amyloid b (Ab) plaque and tau pathology, we overexpressed several mouse cytokines, chemokine receptors and soluble innate immune receptors in Amyloid precursor protein (APP) expressingTgCRND8 mice or tau transgenic mice. Methods: Using adeno associated virus (AAV2/1) mediated gene delivery in neonatal mice brain, we effectively demonstrate that this technique allows us to achieve high levels of transgene expression while 1) bypassing the need to create bigenic mice to test hypotheses in a rapid cost-effective manner, 2) testing different mediators on a uniform genetic background and 3) modeling cell non autonomous signaling in vivo. Results: We show that in TgCRND8 mice brain, expression of 1) inflammatory cytokines reduce Ab plaques; 2) anti-inflammatory cytokines exacerbate Ab pathology; and 3) modulating the innate immune receptors using soluble Toll-like receptors (sTLR4 and sTLR5) decrease Ab pathology. On the other hand, over-expression of inflammatory cytokines increase soluble phosphorylated tau while differentially affecting insoluble tau levels in tau transgenic mice. Conclusions: Understanding how innate immune activation states regulate tau and Abpathology could reveal novel therapeutic approaches for AD, including re-purposing current forms of immune therapy already tested in the clinic. Our ongoing studies show that manipulating innate immunity can be a double edged sword, and that development of any innate immune therapy for AD will need to be finely tuned and extensively validated in order to be truly effective. We demonstrate that though engagement of the innate immune system early on during disease pathogenesis may be beneficial in restricting the development of Ab plaques, this may potentially exacerbate tau pathology and negatively affect proteostasis. Therefore, our study strongly argues for a cautious re-examination of unwarranted side-effects of immune based therapies and calls for exploring the therapeutic potential of decoy receptors in preclinical mouse models ofAD as a means of restricting AD pathology while simultaneously minimizing bystander toxicity.

Published
2014
Full Text
View/download PDF

20. P2‐050: CHANGES IN THE HUMAN HIPPOCAMPAL PROTEOME DURING ALZHEIMER'S DISEASE

Author

Annemieke J.M. Rozemuller, Guus Smit, David Hondius, Roel C. van der Schors, Jeroen J.M. Hoozemans, Saskia M. van der Vies, Elise S. van Haastert, Pim van Nierop, and Ka Wan Li

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Health Policy, Proteome, Neurology (clinical), Disease, Geriatrics and Gerontology, Biology, Hippocampal formation, Neuroscience
Published
2014
Full Text
View/download PDF

21. IC‐P‐057: CLASSIFICATION OF PATHOLOGY USING BRAIN SUBSTRUCTURE VOLUMES IN POST MORTEM CONFIRMED DEMENTIAS

Author

Nick C. Fox, Philip Scheltens, Frederik Barkhof, Lorna Harper, Jonathan M. Schott, Gerard R. Ridgway, Emma J. Burton, John T. O'Brien, Annemieke J.M. Rozemuller, and Femke H. Bouwman

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Pathology, medicine.medical_specialty, Developmental Neuroscience, Epidemiology, business.industry, Health Policy, Medicine, Substructure, Neurology (clinical), Geriatrics and Gerontology, business
Published
2014
Full Text
View/download PDF

22. P1‐313: NEUROINFLAMMATION IN ALZHEIMER'S DISEASE PATHOLOGY DECREASES WITH AGE

Author

Elise S. van Haastert, Willem A. van Gool, Piet Eikelenboom, Annemieke J.M. Rozemuller, and Jeroen J.M. Hoozemans

Subjects
Pathology, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, medicine, Neurology (clinical), Geriatrics and Gerontology, business, Neuroinflammation
Published
2014
Full Text
View/download PDF

23. P3‐041: BRAIN DEPOSITION OF PYROGLUTAMATE Aβ IN Aβ AMYLOIDOSIS

Author

Giorgio Giaccone, Stephan Schilling, Annemieke J.M. Rozemuller, Martin Kleinschmidt, Nenad Bogdanovic, Hans-Ulrich Demuth, Maria Luisa Moro, and Fabrizio Tagliavini

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Epidemiology, Chemistry, Health Policy, Amyloidosis, Biophysics, medicine, Neurology (clinical), Geriatrics and Gerontology, medicine.disease, Deposition (chemistry)
Published
2014
Full Text
View/download PDF

24. P1‐015: PROTEIN KINASE ACTIVITY DECREASES WITH BRAAK STAGE IN HIPPOCAMPAL POSTMORTEM BRAIN TISSUE AS REVEALED BY USING A PEPTIDE‐BASED MICROARRAY PLATFORM

Author

Annemieke J.M. Rozemuller, Wiesje M. van der Flier, Riet Hilhorst, Andrea F.N. Rosenberger, Philip Scheltens, Jeroen J.M. Hoozemans, and Saskia M. van der Vies

Subjects
chemistry.chemical_classification, Postmortem brain, Epidemiology, Health Policy, Peptide, Biology, Hippocampal formation, Molecular biology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, chemistry, Neurology (clinical), Geriatrics and Gerontology, Stage (cooking), Protein kinase A, Microarray platform
Published
2014
Full Text
View/download PDF

25. P2–207: CSF beta‐amyloid 1–42, but not CSF tau, phosphorylated tau or hippocampal atrophy on MRI relate to Alzheimer's disease pathology load in the brain

Author

Arianne Bechten, Charlotte E. Teunissen, Niki S.M. Schoonenboom, Annemieke J.M. Rozemuller, Frederik Barkhof, Philip Scheltens, Pieter Jelle Visser, Femke H. Bouwman, Wiesje M. van der Flier, and Sabine Vrugte

Subjects
Pathology, medicine.medical_specialty, Amyloid, Epidemiology, business.industry, Health Policy, Disease, Hippocampal atrophy, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Tau phosphorylation, Medicine, Neurology (clinical), Geriatrics and Gerontology, Beta (finance), business
Published
2013
Full Text
View/download PDF

26. O4‐05‐02: Clinicopathological correlations of the frontal lobe syndrome: Results of a large brain bank study

Author

Annemieke J.M. Rozemuller, Wouter Kamphorst, Welmoed A. Krudop, Sjanne Bosman, Yolande A.L. Pijnenburg, and Jeroen J. G. Geurts

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Frontal lobe, Epidemiology, business.industry, Health Policy, Medicine, Brain bank, Neurology (clinical), Anatomy, Geriatrics and Gerontology, business
Published
2012
Full Text
View/download PDF

27. F1‐01‐06: Juvenile dementia and review of pathological findings of very early presenile Alzheimer's disease

Author

Annemieke J.M. Rozemuller

Subjects
Pediatrics, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Disease, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, medicine, Dementia, Juvenile, Neurology (clinical), Geriatrics and Gerontology, business, Pathological
Published
2011
Full Text
View/download PDF

28. P2‐263: Oxidative stress and tight junctions alterations in capillary cerebral amyloid angiopathy

Author

Annemieke J.M. Rozemuller, Elga de Vries, Anna Carrano, and Jack van Horssen

Subjects
Tight junction, Epidemiology, Capillary action, Chemistry, Health Policy, medicine.disease, medicine.disease_cause, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, medicine, Biophysics, Neurology (clinical), Cerebral amyloid angiopathy, Geriatrics and Gerontology, Oxidative stress
Published
2010
Full Text
View/download PDF

29. P1‐294: Protein kinase activity profiling and identification of signalling pathways involved in Alzheimer's disease

Author

Jeroen J.M. Hoozemans, Riet Hilhorst, Rob Ruijtenbeek, Annemieke J.M. Rozemuller, Saskia M. van der Vies, Philip Scheltens, and Elise S. van Haastert

Subjects
Epidemiology, Health Policy, Cyclin-dependent kinase 5, Cyclin-dependent kinase 2, Biology, MAP3K7, MAP3K8, MAP2K7, Cell biology, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, biology.protein, ASK1, Neurology (clinical), c-Raf, Geriatrics and Gerontology, Protein kinase A
Published
2010
Full Text
View/download PDF

30. P2‐297: Increased expression of a single‐pass transmembrane glycoprotein and its ligand in Alzheimer's disease brain

Author

Claus A. Andersen, David Hondius, Thierry Hazes, Giuseppe Pollio, Annemieke J.M. Rozemuller, Tamara Seredenina, Alessia Tardetti, Georg C. Terstappen, Jeroen J.M. Hoozemans, Andrea Caricasole, and Elise S. van Haastert

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Single pass, Developmental Neuroscience, Myelin-associated glycoprotein, Epidemiology, Chemistry, Health Policy, Transmembrane glycoprotein, Neurology (clinical), Geriatrics and Gerontology, Ligand (biochemistry), Cell biology
Published
2010
Full Text
View/download PDF

31. P1‐365: Amyloid‐associated proteins, neuroinflammation and neurofibrillary degeneration in Alzheimer's disease and cerebral prion amyloidosis

Author

Jeroen J.M. Hoozemans, Jan Beekhuis, Casper Jansen, Annemieke J.M. Rozemuller, Anna Carrano, Elise S. van Haastert, and David Hondius

Subjects
Pathology, medicine.medical_specialty, Amyloid, Epidemiology, business.industry, Health Policy, Amyloidosis, Disease, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Neurofibrillary degeneration, medicine, Neurology (clinical), Geriatrics and Gerontology, business, Neuroinflammation
Published
2010
Full Text
View/download PDF

32. P1‐209: Capillary cerebral amyloid angiopathy with dyshoric changes: Clinical and pathological characteristics

Author

Annemieke J.M. Rozemuller, W.A. van Gool, Jeroen J.M. Hoozemans, Elga de Vries, Piet Eikelenboom, Elise S. van Haastert, Jack van Horssen, Anna Carrano, and Edo Richard

Subjects
Pathology, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, medicine, Neurology (clinical), Cerebral amyloid angiopathy, Geriatrics and Gerontology, business, Pathological
Published
2010
Full Text
View/download PDF

33. P2‐163: Thimet oligopeptidase expression is increased in Alzheimer's disease brain

Author

Jeroen J.M. Hoozemans, Annemieke J.M. Rozemuller, Thierry Hazes, Guiseppe Pollio, Elise S. van Haastert, Andrea Caricasole, and Georg C. Terstappen

Subjects
Psychiatry and Mental health, Cellular and Molecular Neuroscience, Thimet oligopeptidase, Developmental Neuroscience, Epidemiology, Health Policy, Cancer research, Neurology (clinical), Disease, Geriatrics and Gerontology, Biology
Published
2008
Full Text
View/download PDF

34. P2‐201: ER stress is associated with phosphorylation of tau in the pathology of Alzheimer's disease and Pick's disease

Author

Frank Baas, Diana A.T. Nijholt, Elise S. van Haastert, Annemieke J.M. Rozemuller, Wiep Scheper, Rob Zwart, and Jeroen J.M. Hoozemans

Subjects
Pathology, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Disease, medicine.disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, medicine, Unfolded protein response, Phosphorylation, Pick's disease, Neurology (clinical), Geriatrics and Gerontology, business
Published
2008
Full Text
View/download PDF

35. P1‐426: Microglia/macrophages, atroglia and neuritic changes in extensive capillary amyloid angiopathy in patients with rapidly progressive dementia

Author

Wim G. M. Spliet, Annemieke J.M. Rozemuller, Jeroen M.M. Hoozemans, and Seroer Al-muhana

Subjects
Rapidly progressive dementia, Pathology, medicine.medical_specialty, Epidemiology, business.industry, Health Policy, Microglia macrophages, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, Medicine, In patient, Neurology (clinical), Geriatrics and Gerontology, business, Amyloid angiopathy
Published
2008
Full Text
View/download PDF

36. P4‐160: Transglutaminase 1, Transglutaminase 2 and Transglutaminase‐catalyzed cross‐links colocalize with the pathological lesions in Alzheimer's disease brain

Author

Jeroen J.M. Hoozemans, Sentini C.S. Grunberg, Annemieke J.M. Rozemuller, John G.J.M. Bol, Benjamin Drukarch, and Micha M.M. Wilhelmus

Subjects
Pathology, medicine.medical_specialty, biology, Epidemiology, Tissue transglutaminase, Chemistry, Health Policy, Colocalization, Disease, Psychiatry and Mental health, Cellular and Molecular Neuroscience, Developmental Neuroscience, biology.protein, medicine, Neurology (clinical), Geriatrics and Gerontology, Pathological
Published
2008
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results